GVOKE HYPOPEN: payments to doctors
Payments that named GVOKE HYPOPEN as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $2.1M
- Providers
- 23,610
- Transactions
- 61,023
- Average per transaction
- $35
The per-transaction average — $35 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 23,610 providers the average total is $91, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | $2,140,728 | 100.0% |